Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
SES AI
SES
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By geography
See full
Asia Pacific
92%
-8.0%
Other financials
Income statement
See full
Revenue
$6.7M
+15.8%
Gross profit
$1.2M
-73.3%
Operating income
-$17.9M
+23.2%
Net income
-$12.1M
+2.7%
EPS (diluted)
-$0.04
0.0%
Balance sheet
See full
Cash & equivalents
$46.9M
-16.3%
Total debt
$7.7M
-18.9%
Total equity
$203.2M
-24.7%
Total assets
$253.5M
-17.1%
Cash flow
See full
Operating cash flow
-$19.8M
+13.3%
CapEx
$330.0K
-64.0%
Free cash flow
-$20.1M
+15.2%
Valuation
See full
Market cap
$325.08M
+5.5%
Enterprise value
$285.86M
+9.3%
P/S
14.8×
-27.2×
Profitability
See full
Gross margin
36.3%
-39.1pp
Operating margin
-352.3%
-153pp
Net margin
-331.7%
-142pp
FCF margin
-262.8%
-115pp
Returns & leverage
See full
Return on equity
-30.7%
-0.7pp
Debt / equity
0×
0.0×
Current ratio
6.9×
-8.8×